Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€32.45

€32.45

0.310%
0.1
0.310%
-

-

 
18.04.24 / Frankfurt WKN: 870481 / Name: Guerbet / Stock / Pharmaceuticals / Small Cap /
Your prediction

Guerbet S.A. Stock

Guerbet S.A. gained 0.310% compared to yesterday.

Pros and Cons of Guerbet S.A. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Guerbet S.A. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Guerbet S.A. 0.310% -1.517% 3.180% 93.385% 68.309% -2.259% -42.054%
Boiron S.A. -0.600% -1.039% 3.571% -16.521% -15.995% -14.487% -34.736%
Virbac S.A. 1.090% 3.938% 11.128% 29.877% 2.925% 46.047% 142.136%
Onxeo S.A. -7.680% -9.833% 12.708% -65.868% -28.581% -85.359% -87.073%

News

Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: 2023 full-year results.
Guerbet: 2023 full-year results.
Guerbet: 2023 full-year results.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.